Ligand binding to thromboxane receptors on human platelets: correlation with biological activity
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
Advanced Organic Chemistry: Reactions, Mechanisms, and Structure
1977 • 4,066 citations
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
1975 • 3,075 citations
Prostaglandin Endoperoxides. Novel Transformations of Arachidonic Acid in Human Platelets
1974 • 1,410 citations
Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides
1976 • 533 citations
Prostaglandin Endoperoxides. A New Concept Concerning the Mode of Action and Release of Prostaglandins
1974 • 495 citations
Thromboxanes: Selective Biosynthesis and Distinct Biological Properties
1976 • 390 citations
A Theoretical Study of the Binding of Small Molecules to a Polymerizing Protein System. A Model for Allosteric Effects*
1967 • 214 citations
The synthesis of prostaglandin endoperoxide analogs
1975 • 198 citations
Prostaglandin Endoperoxides IX. Characterization of Rabbit Aorta Contracting Substance (RCS) from Guinea Pig Lung and Human Platelets
1975 • 179 citations
An endoperoxide aggregator (LASS), formed in platelets in response to thrombotic stimuli-purification, identification and unique biological significance
1974 • 178 citations
Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition
1976 • 176 citations
Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.
1980 • 128 citations
13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.
1979 • 113 citations
Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.
1979 • 108 citations
Effect of Prostaglandin E2 and Aspirin on the Secondary Aggregation of Human Platelets
1972 • 101 citations
Potent luteolytic agents related to prostaglandin F2α
1974 • 94 citations
Highly stereoselective conversion of prostaglandin A2 to the 10, 11.alpha.-oxido derivative using a remotely placed exogenous directing group
1973 • 62 citations
Discrimination between platelet prostaglandin receptors with a specific antagonist of bisenoic prostaglandins
1977 • 59 citations
In vivo PHARMACOLOGICAL STUDIES ON THE INTERACTIONS BETWEEN TRYPTAMINE AND 5‐HYDROXYTRYPTAMINE
1981 • 41 citations
Synthesis of prostaglandin H2
1979 • 40 citations
Prostaglandins and platelet function.
1976 • 35 citations
Prostaglandin F2α antagonizes thromboxane A2-induced human platelet aggregation
1982 • 29 citations
Synthesis of prostanoids with bicyclo[2.2.1]heptane, bicyclo[3.1.1]heptane and bicyclo[2.2.2]octane ring systems. Activities of 15-hydroxy epimers on human platelets
1982 • 24 citations
Stereo-dependent inhibition of human platelet function by the optical isomers of trimetoquinol
1981 • 24 citations
Synthesis of thromboxane A2 analog DL-(9,11), (11,12)-dideoxa-(9,11)-epithio-(11,12)-methylene-thromboxane A2
1981 • 18 citations
ACTIONS OF 16‐ARYLOXY ANALOGUES OF PROSTAGLANDIN F2α ON PREPARATIONS RESPONSIVE TO PROSTAGLANDIN ENDOPEROXIDES
1977 • 16 citations
THROMBOXANE-LIKE ACTIVITY OF PROSTANOIDS WITH AROMATIC SUBSTITUENTS AT C16 AND C17
1979 • 16 citations
Effects of thromboxane antagonist EP 045 on platelet aggregation.
1983 • 15 citations
Antiplatelet actions of trimetoquinol isomers: evidence for inhibition of a prostaglandin-independent pathway of platelet aggregation
1982 • 11 citations
Syntheses of thromboxane A2 analogs: Thia- and dithiathromboxane A2.
1983 • 1 citations